Skip to main content

Table 5 Perioperative NT-proBNP in patients with complete data sets of NT-proBNP Preop and POD1 or NT-proBNP Preop and POD3 and EuroSCORE II ≥ 4.15

From: The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study

VariablesEuroSCORE II ≥ 4.15 (n = 81a/83b)Glutamate
(n = 41a/47b)
Control
(n = 37a/36b)
p-value
NT-proBNP Prea (ng•L−1)1090 [460–2430]980 [435–2057]1340 [460–2910]0.38
NT-proBNP POD1a (ng•L−1)4390 [2950–6300]3802 [2715–5570]4690 [3060–6650]0.19
Delta NT-proBNP POD1-Prea (ng•L−1)2800 [1650–4760]2653 [1540–3675]3050 [2030–5560]0.13
NT-proBNP Preb (ng•L−1)970 [425–2345]740 [395–1810]1265 [465–2985]0.10
NT-proBNP POD3b (ng•L−1)6650 [3840–10,085]5140 [3490–7423]8220 [5339–14,550]0.002
Delta NT-proBNP POD3-Preb (ng•L−1)5210 [3115–8595]3900 [2995–6260]6745 [3455–12,686]0.012
  1. Data given as medians [interquartile range] or percentages (number)
  2. Preop preoperative, POD postoperative day
  3. aPatients with complete data sets of NT-proBNP Preop and POD1
  4. bPatients with complete data sets of NT-proBNP Preop and POD3